Edgestream Partners L.P. Invests $657,000 in CVS Health Corporation $CVS

Edgestream Partners L.P. acquired a new position in shares of CVS Health Corporation (NYSE:CVS) in the first quarter, Holdings Channel.com reports. The fund acquired 9,142 shares of the pharmacy operator’s stock, valued at approximately $657,000.

A number of other institutional investors have also added to or reduced their stakes in the company. Kentucky Retirement Systems increased its position in shares of CVS Health by 25.0% during the 1st quarter. Kentucky Retirement Systems now owns 98,269 shares of the pharmacy operator’s stock valued at $7,033,000 after purchasing an additional 19,633 shares during the last quarter. Bull Harbor Capital LLC purchased a new stake in CVS Health in the first quarter worth approximately $345,000. Strategic Investment Advisors MI grew its position in CVS Health by 9.6% during the first quarter. Strategic Investment Advisors MI now owns 9,741 shares of the pharmacy operator’s stock valued at $700,000 after acquiring an additional 853 shares during the last quarter. IFS Group LLC purchased a new position in shares of CVS Health during the first quarter worth approximately $645,000. Finally, Strategic Planning Inc. raised its stake in shares of CVS Health by 1.2% during the first quarter. Strategic Planning Inc. now owns 146,342 shares of the pharmacy operator’s stock worth $10,510,000 after acquiring an additional 1,733 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on the stock. Barclays upped their price objective on shares of CVS Health from $101.00 to $106.00 and gave the company an “overweight” rating in a research note on Tuesday, May 26th. HSBC restated a “hold” rating and set a $103.00 price target on shares of CVS Health in a research report on Monday, July 6th. Argus lifted their price objective on CVS Health from $90.00 to $104.00 and gave the stock a “buy” rating in a report on Thursday, May 14th. Royal Bank Of Canada boosted their target price on CVS Health from $107.00 to $113.00 and gave the company an “outperform” rating in a research note on Thursday, July 9th. Finally, TD Cowen raised their price target on CVS Health from $105.00 to $110.00 and gave the stock a “buy” rating in a research report on Monday, May 11th. Twenty-one investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, CVS Health presently has a consensus rating of “Moderate Buy” and an average price target of $105.67.

CVS Health Price Performance

CVS stock opened at $104.27 on Wednesday. The stock has a market capitalization of $133.04 billion, a price-to-earnings ratio of 45.93, a PEG ratio of 1.03 and a beta of 0.61. The firm’s 50-day moving average price is $101.96 and its two-hundred day moving average price is $87.43. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.78. CVS Health Corporation has a 12-month low of $61.35 and a 12-month high of $110.68.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, May 6th. The pharmacy operator reported $2.57 earnings per share for the quarter, topping analysts’ consensus estimates of $2.21 by $0.36. CVS Health had a net margin of 0.72% and a return on equity of 11.88%. The company had revenue of $100.43 billion during the quarter, compared to analyst estimates of $94.99 billion. During the same period in the prior year, the business posted $2.25 earnings per share. CVS Health’s revenue for the quarter was up 6.2% on a year-over-year basis. As a group, equities analysts predict that CVS Health Corporation will post 7.46 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were paid a $0.665 dividend. The ex-dividend date of this dividend was Thursday, July 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 2.6%. CVS Health’s dividend payout ratio (DPR) is presently 117.18%.

Insider Activity

In related news, EVP Tilak Mandadi sold 69,551 shares of the company’s stock in a transaction on Friday, May 8th. The stock was sold at an average price of $89.58, for a total value of $6,230,378.58. Following the sale, the executive vice president directly owned 10,133 shares of the company’s stock, valued at $907,714.14. This represents a 87.28% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Larry Robbins sold 370,462 shares of the company’s stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $93.45, for a total transaction of $34,619,673.90. Following the completion of the sale, the director directly owned 4,824,799 shares in the company, valued at $450,877,466.55. This represents a 7.13% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 3,441,551 shares of company stock valued at $323,703,977. Corporate insiders own 0.85% of the company’s stock.

Key Stories Impacting CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Analysts expect another solid quarter, with revenue and earnings growth supported by Aetna initiatives and CVS’s pharmacy-benefit operations. A stronger-than-expected report or guidance upside could provide additional support for CVS Health (CVS). CVS’s Turnaround Faces Its Next Test
• Positive Sentiment: Recent analysis highlights early evidence of Aetna margin improvement, suggesting management’s turnaround plans may be gaining traction. That progress could help sustain the stock’s strong advance over the past year if confirmed in the earnings release. CVS Health Stock Surged On An Aetna Recovery
• Neutral Sentiment: CVS’s AI Learning Academy received two Gold Stevie Awards and one Silver award for employee reskilling, AI workforce innovation, and learning programs. The recognition supports the company’s long-term workforce strategy but is unlikely to materially affect near-term earnings. CVS Health earns Stevie Awards
• Negative Sentiment: The stock’s recent gains have raised expectations ahead of earnings. Any renewed concerns about Aetna medical costs, Caremark profitability, or conservative guidance could lead to profit-taking, particularly with shares trading near their 12-month high.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.